title: Osteoporosis prevention, detection, and treatment. A mandate for primary care physicians.
abstract: Prevention of bone loss through healthy lifestyle choices offers the greatest promise of minimizing fracture incidence. Safe, effective therapeutic options are available when drug therapy is prudent. Newer bisphosphonates, selective estrogen receptor modulators, and HRT delivery systems will soon be available to offer an even larger menu of choices for osteoporosis prevention and treatment. By implementing appropriate treatment, we can prevent bone loss, reduce fracture incidence, and improve function and quality of life, even in patients who have previously experienced fractures.
authors.affiliation: University of California at Los Angeles, UCLA School of Medicine, USA. clambing@venturafpr.com
authors.forename: C L
authors.initials: CL
authors.lastname: Lambing
mesh_terms: D019386:Alendronate / Q000627:therapeutic use; D001846:Bone Development; D003720:Densitometry; D015914:Estrogen Replacement Therapy; D005194:Family Practice; D005260:Female; D006620:Hip Fractures / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D008297:Male; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D012307:Risk Factors
chemical_list: D019386:Alendronate